Drug Database
Back to search

Belgium· BE-AMP-SAM108972-00

Visken 15 mg

A pindolol product containing pindolol, registered in Belgium by Novartis Pharma. The same ATC class is registered in 7 of our 19 countries.

ATC C07AA03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVisken 15 mgATCC07AA03REGISTER NO.BE-AMP-SAM108972-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pindololAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pindolol is registered in 7 of 19 countries.

Countries holding a registration under ATC C07AA03 (pindolol), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search pindolol products by name

Pindolol · ATC C07AA03

7 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Germany
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pindolol costs, country by country.

Normalised to the WHO defined daily dose (15 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pindolol · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Pindolol
Manufacturer
Novartis Pharma
Country
Belgium (BE)
ATC code
C07AA03
ATC class
Pindolol
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0097980

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

262 interactions on record for pindolol.

Graded by severity as the source publishes them — 31 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pindolol against other medicinesHow interaction checks work

Pindolol · interactions on record

262 records

  • 31 severe
  • 182 moderate
  • 20 minor
  • 24 info

Most severe, free to view

  • DolasetronA04AA04severe
  • EpinephrineB02BC09severe
  • EpinephrineC01CA24severe
  • OrciprenalinC01CA29severe

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pindolol in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pindolol products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • Germany · Visken
  • France · Visken, Visken Quinze
  • United Kingdom (Northern Ireland) · Pindolol Amdipharm Uk, Pindolol Amdipharm Uk Limited
  • Italy · Visken

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ecf7e82e-0e96-4acd-8df5-2c8cc0ad4be6
GET /v1/drugs/ecf7e82e-0e96-4acd-8df5-2c8cc0ad4be6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Visken 15 mg",
  "name_fr": "Visken 15 mg",
  "name_nl": "Visken 15 mg",
  "amp_code": "SAM108972-00",
  "strengths": [
    "15.0000",
    "15.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Pindolol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Pindolol",
  "authorisation_numbers": [
    "BE108972"
  ]
}
API referenceMCP serverPlans

See everything about pindolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console